Back to HALO overview

HALO Halozyme Therapeutics PE ratio, current and historical analysis

As of Jun 14, 2024, the HALO stock has a P/E ratio of 20.2. The calculation is based on the latest EPS of $2.45 and the stock price of $49.5 per share. An increase of 8% has been observed in the PE ratio compared to its average of 18.7 of the past four quarters.

HALO PE ratio history

How has HALO's PE ratio performed in the past

The mean historical PE ratio of Halozyme Therapeutics over the last seven years is 33.66. The current 20.2 price-to-earnings ratio is 40% less than the historical average. Analyzing the last seven years, HALO's PE ratio reached its highest point in the Sep 2020 quarter at 146, with a price of $26.28 and an EPS of $0.18. The Mar 2022 quarter saw the lowest point at 12.95, with a price of $39.88 and an EPS of $3.08.


Halozyme Therapeutics PE ratio by year

Maximum annual increase: 173.47% in 2022

Maximum annual decrease: -68.73% in 2021

Year PE ratio Change
2023 17.35 -54.88%
2022 38.45 173.47%
2021 14.06 -68.73%
2020 44.96 N/A
2019 N/A N/A
2018 N/A N/A
2017 44.04 N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

HALO average PE ratio chart

What is the average PE ratio of HALO for the past years

The current PE ratio of HALO is under its 3, 5 and 10-year averages.

3-year avg
5-year avg
10-year avg
15-year avg

HALO PE vs peers

What is HALO's PE ratio compared to its peers

HALO's PE ratio is less than its peer stocks LLY and MNKD, but it is above JNJ's and BAX's.

Stock name PE ratio Market cap
BAX Baxter International Inc 6.46 $17.21B
JNJ Johnson & Johnson 9.54 $350.27B
HALO Halozyme Therapeutics Inc 20.2 $6.3B
MNKD Mannkind Corp 120 $1.31B
LLY ELI LILLY & Co 128.8 $834.88B
PFE Pfizer Inc N/A $156B

Frequently asked questions

What is Halozyme Therapeutics's PE ratio?

As of Jun 14, 2024, HALO stock has a price to earnings ratio of 20.2.

What is the 3-year average PE ratio for Halozyme Therapeutics (HALO)?

Over the last 3 years, the average PE ratio for HALO stock is 21.11.

What is the 5-year average PE ratio for Halozyme Therapeutics (HALO)?

Over the last 5 years, the average PE ratio for HALO stock is 31.93.

What is the highest PE ratio for HALO?

Over the last seven years, the quarterly PE ratio reached its highest level at 146 in the Sep 2020 quarter.

How does the current PE ratio for HALO compare to its historical average?

HALO's current price to earnings ratio is 40% below its 7-year historical average.

How is HALO's PE ratio calculated (Halozyme Therapeutics PE ratio formula)?

To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 14, 2024), Halozyme Therapeutics's share price is $49.5. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.45. Therefore, Halozyme Therapeutics's price to earnings ratio for today is 20.2. PE RATIO(20.2) = STOCK PRICE($49.5) / TTM EPS($2.45)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.